Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drusen Mega and Sertraline for Chronic Subjective Endotic Tinnitus
NCT05646693Phase 2Unknown
- Sponsor
- Universidad de Guadalajara
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus, sponsored by Universidad de Guadalajara. Primary endpoints: Superoxide Dismutase at 90 days and Catalase at 90 days. Status: unknown.
02
Conditions
tinnitus
Beyond the preview
Go deeper on NCT05646693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05646693.